October 9, 2013

A new law in Maine will allow consumers to purchase drugs by mail order from some pharmacies overseas, according to published reports.

October 8, 2013

A Republican congressman from Alabama has proposed a stopgap bill that would fund the Food and Drug Administration through the middle of December or until the government shutdown ends, though it is unlikely to pass in the Senate.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

October 8, 2013

GreenLight Rx is offering a line of medicine bottles aimed at elderly people and those suffering from such conditions as arthritis, the company said.

October 8, 2013

Consumers paid more for prescriptions as the country's economy recovered from the recession, according to a new study.

October 7, 2013

Late-stage clinical data support the efficacy of an experimental drug under development by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis, the two companies said.

October 7, 2013

Doctors have continued prescribing antibiotics for mild conditions that don't require them despite decades of efforts by government authorities to discourage the practice, according to a new study.

October 7, 2013

Next year, the share of brand-name drugs paid by Medicare Part D beneficiaries will drop to 47.5%. The share of generics will drop to 72%, according to a report published Monday in the Wall Street Journal.

October 3, 2013

The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

October 3, 2013

Research Now announced the launch of its Diabetes Panel, a collection of 336,000 deeply-profiled panelists in the United States and Canada who have been diagnosed with Type 1 diabetes, Type 2 diabetes, high blood pressure or obesity.

October 3, 2013

In preparation for flu season, actress Amanda Peet, ambassador of the UN Foundation's Shot@Life program, received her annual flu shot at Walgreens' flagship store in New York City to support its "Get a Shot, Give a Shot" campaign.

October 2, 2013

Actavis has appointed the board of directors for the division it recently created as part of its acquisition of Ireland-based Warner Chilcott, the drug maker said.

October 2, 2013

Drug maker Valeant Pharmaceuticals International is joining an effort to oppose domestic violence, the company said Wednesday.

October 1, 2013

Ireland's High Court has approved Actavis' acquisition of Warner Chilcott, the drug makers said.

October 1, 2013

The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

October 1, 2013

The Healthcare Distribution Management Association on Tuesday announced the re-election of David Neu, president of AmerisourceBergen Drug Corp. as chairman of its board of directors. Ted Scherr, president and CEO of Dakota Drug, also was re-elected as vice chairman.

October 1, 2013

The Department of Health and Human Services will furlough more than half of its employees due to the government shutdown, the agency said.

September 30, 2013

The National Criminal Justice Association has recognized a program to combat prescription drug abuse in Arizona as the best such program in the west of the country.

September 30, 2013

The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

September 30, 2013

The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

September 30, 2013

The Healthcare Distribution Management Association on Saturday added its voice supporting national pharmaceutical traceability legislation (Drug Quality and Security Act/H.R. 3204).

September 27, 2013

FlavoRx will start recognizing independent pharmacies that have implemented its program next month, the company said Friday.

September 24, 2013

Belgian drug maker Ablynx is licensing an experimental treatment for rheumatoid arthritis and lupus to U.S. drug maker AbbVie in a deal worth up to $840 million.

September 24, 2013

The Food and Drug Administration has approved a new dosage strength for a chronic pain patch made by Purdue Pharma, the drug maker said Tuesday.